SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Ekstrom S) srt2:(2000-2004)"

Search: WFRF:(Ekstrom S) > (2000-2004)

  • Result 1-27 of 27
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Andres, E., et al. (author)
  • Selected recent results from AMANDA
  • 2001
  • In: ICHEP 2000. Proceedings of the 30th International Conference on High Energy Physics. - : World Scientific. ; , s. 965-968
  • Conference paper (peer-reviewed)abstract
    • We present a selection of results based on data taken in 1997 with the 302-PMT Antarctic Muon and Neutrino Detector Array-B10 ("AMANDA-B10") array. Atmospheric neutrinos created in the northern hemisphere are observed indirectly through their charged current interactions which produce relativistic, Cherenkov-light-emitting upgoing muons in the South Pole ice cap. The reconstructed angular distribution of these events is in good agreement with expectation and demonstrates the viability of this ice-based device as a neutrino telescope. Studies of nearly vertical upgoing muons limit the available parameter space for WIMP dark matter under the assumption that WIMPS are trapped in the earth's gravitational potential well and annihilate with one another near the earth's center.
  •  
2.
  • Ahrens, J., et al. (author)
  • Results from AMANDA
  • 2001
  • In: Proceedings, 9th International Workshop, Venice, Italy, March 6-9, 2001. Vol. 1, 2. ; , s. 569-580
  • Conference paper (peer-reviewed)
  •  
3.
  • Karle, A., et al. (author)
  • Observation of high energy atmospheric neutrinos with AMANDA
  • 2000
  • In: AIP Conference Proceedings. - : American Institute of Physics (AIP). ; , s. 823-827
  • Conference paper (peer-reviewed)abstract
    • In 1997 the Antarctic Muon and Neutrino Detector Array (AMANDA) started operating with 10 strings. In an analysis of data taken during the first year of operation 188 atmospheric neutrino candidates were found. Their zenith angle distribution agrees with expectations based on Monte Carlo simulations. A preliminary upper limit is given on a diffuse flux of high energy neutrinos of astrophysical origin.
  •  
4.
  • Niessen, Peter, et al. (author)
  • Recent results from the amanda experiment
  • 2003
  • In: Proceedings of 38th Rencontres de Moriond on Electroweak Interactions and Unified Theories 15-22 Mar 2003. Les Arcs, France.
  • Conference paper (peer-reviewed)abstract
    • AMANDA (Antarctic Muon And Neutrino Detector Array) is a neutrino telescope built under the southern polar icecap and its scope is to explore the possibility to detect high energy cosmic neutrinos. This should generate insight into the powerful celestial objects where acceleration mechanisms can bring up to 10 20   eV. We describe the achievements and results from the AMANDA-B10 prototype and the preliminary results from the current AMANDA-II detector which show dramatic increase in sensitivity.
  •  
5.
  • Wiebusch, C., et al. (author)
  • Results from AMANDA
  • 2002
  • In: Modern Physics Letters A. - : Institution of Electrical Engineers (IEE). - 0217-7323 .- 1793-6632. ; 17:31, s. 2019-2037
  • Journal article (peer-reviewed)abstract
    • The Antarctic Muon and Neutrino Detector Array (AMANDA) is a high-energy neutrino telescope operating at the geographic South Pole. It is a lattice of photomultiplier tubes buried deep in the polar ice. The primary goal of this detector is to discover astrophysical sources of high energy neutrinos. We describe the detector methods of operation and present results from the AMANDA-B10 prototype. We demonstrate the improved sensitivity of the current AMANDA-II detector. We conclude with an outlook to the envisioned sensitivity of the future IceCube detector.
  •  
6.
  • Ahrens, J., et al. (author)
  • Initial results from AMANDA
  • 2001
  • In: 21st Rencontres de Moriond Workshop on Very High-Energy Phenomena in the Universe.
  • Conference paper (peer-reviewed)
  •  
7.
  •  
8.
  •  
9.
  • Bilger, R, et al. (author)
  • Spectator tagging in quasi-free pn-reactions on deuterium at PROMICE/WASA, CELSIUS
  • 2000
  • In: Nuclear Physics A. - : Elsevier Science B.V. Holland. ; , s. 1053c-1056c
  • Conference paper (peer-reviewed)abstract
    • A set of silicon detectors has been added to the PROMICE/WASA (P/W) experiment at CELSIUS. These detectors have been used for spectator-proton tagging in proton deuteron collisions to investigate proton-neutron reactions at intermediate energies. The perf
  •  
10.
  • Brodowski, W, et al. (author)
  • Exclusive measurement of pp -> pp pi(+)pi(-) at CELSIUS
  • 2000
  • In: ACTA PHYSICA POLONICA B. - : ACTA PHYSICA POLONICA B, JAGELLONIAN UNIV, INST PHYSICS. - 0587-4254. ; 31:10-11, s. 2295-2298
  • Journal article (peer-reviewed)abstract
    • With the PROMICE/WASA detector setup at CELSIUS the reaction pp --> NN pi pi has been measured in the energy range from 650 to 775 MeV. These data constitute the first exclusive high-statistics measurements on a pure hydrogen target, supplying both differ
  •  
11.
  •  
12.
  • Bilger, R, et al. (author)
  • Cross sections of the pp -> pp pi(0) reaction between 310 and 425 MeV
  • 2001
  • In: NUCLEAR PHYSICS A. - : ELSEVIER SCIENCE BV. - 0375-9474. ; 693:3-4, s. 633-662
  • Journal article (peer-reviewed)abstract
    • Extensive kinematically complete measurements of the pp --> pp pi (0) reaction have been made at six beam energies: 310, 320, 340, 360, 400, and 425 MeV. Angles and energies of both final-state protons are extracted from the forward detector system of the
  •  
13.
  •  
14.
  • Borrebaeck, Carl, et al. (author)
  • Protein chips based on recombinant antibody fragments: A highly sensitive approach as detected by mass spectrometry
  • 2001
  • In: BioTechniques. - 0736-6205. ; 30:5, s. 1126-1126
  • Journal article (peer-reviewed)abstract
    • With the human genome in a first sequence draft and several other genomes being finished this year, the existing information gap between genomics and proteomics is becoming increasingly evident. The analysis of the proteome is, however, much more complicated because the synthesis and structural requirements of functional proteins are different from the easily handled oligonucleotides for which a first analytical breakthrough already has come in the use of DNA chips. In comparison with the DNA microarrays, the protein arrays, or protein chips, offer the distinct possibility of developing a rapid global analysis of the entire proteome. Thus, the concept of comparing proteomic maps of healthy and diseased cells may allow us to understand cell signaling and metabolic pathways and will form a novel base for pharmaceutical companies to develop future therapeutics much more rapidly. This report demonstrates the possibilities of designing protein chips based on specially constructed, small recombinant antibody fragments using nanostructure surfaces with biocompatible characteristics, resulting in sensitive detection in the 600-amol range. The assay readout allows the determination of single or multiple antigen-antibody interactions. Mass identity of the antigens, currently with a resolution of 8000, enables the detection of structural modifications of single proteins.
  •  
15.
  • Ekstrom, S., et al. (author)
  • Disposable polymeric high-density nanovial arrays for matrix assisted laser desorption/ionization-time of flight-mass spectrometry: II. Biological applications
  • 2001
  • In: Electrophoresis. - 0173-0835. ; 22:18, s. 3984-3992
  • Journal article (peer-reviewed)abstract
    • A novel disposable high-density matrix assisted laser desorption/ionization (MALDI) target plate made either from polymethylmethacrylate (PMMA) or polycarbonate (PC) is presented where thousands (1200-1600) of samples can be deposited and subsequently, analyzed by MALDI-time of flight (TOF) mass spectrometry. Good reproducibility, was obtained across the plate regardless of position on the target plate with a relative standard deviation (RSD) on the peak intensity of typically 30% calculated from data generated by analysis of a 10 nM peptide mixture of angiotensin. I, II, III and bradykinin. The nanovial array format combined with microdispensing technology makes It possible to carry out in-vial, chemistry on deposited samples. This is demonstrated by the analysis of peptides from beta -casein and subsequent in-vial dephosphorylation of its phosphopeptides at 10 fmol levels by microdispensing of alkaline phosphatase, into the nanovial. The mass spectra obtained from these polymeric targets provides can also be used in high sensitivity applications as shown by peptide mass fingerprinting of human fibroblast proteins separated by two-dimensional gel, electrophoresis.
  •  
16.
  • Ekstrom, S., et al. (author)
  • Signal amplification using "spot on-a-chip" technology for the identification of proteins via MALDI-TOF MS
  • 2001
  • In: Analytical Chemistry. - : American Chemical Society (ACS). - 1520-6882 .- 0003-2700. ; 73:2, s. 214-219
  • Journal article (peer-reviewed)abstract
    • The presented "spot-on-a-chip" technology enables easy enrichment of samples in the low nanomolar (1-5 nM) range and provides a fast and reliable automated sample preparation method for performing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis with high sensitivity and throughput. Through microdispensing, which allows accurate deposition of 60-pL droplets, dilute samples were enriched by making multiple droplet depositions in nanovials. The sample was confined to a defined spot area (300 x 300 mum), and multiple depositions increase the surface density of analyte in the nanovial, thereby providing detection of low attomole levels. The impact of the nanovial geometry with respect to the MALDI-TOF MS resolution for peptides deposited in the microfabricated silicon vials was investigated and the optimal geometry and size were determined. The spot-on-a-chip technology, that is, the combination of microdispensing, micromachined silicon nanovials and on-spot enrichment provides a signal amplification of at least 10-50 times as compared to an ordinary sample preparation. The linearity of the enrichment effect is shown by the analysis of a peptide mixture at the 5 nM level. The signal amplification provided by the spot-on-a-chip enrichment is demonstrated by the analysis of relevant biological samples, interleukin-8 from a spiked cell supernatant, and by successful protein identification of an excised spot from a high-sensitivity silver-stained two-dimensional electrophoresis gel separation.
  •  
17.
  •  
18.
  •  
19.
  •  
20.
  •  
21.
  • Kalvius, GM, et al. (author)
  • High pressure mu SR studies: rare earths and related materials
  • 2000
  • In: HYPERFINE INTERACTIONS. - : BALTZER SCI PUBL BV. - 0304-3843. ; 128:1-3, s. 275-303
  • Journal article (peer-reviewed)abstract
    • After a short introduction to mu SR with respect to the study of magnetic properties, followed by a brief outline of the principle of the high pressure-low temperature mu SR spectrometer installed at the Paul Scherrer Institute, we discuss some measuremen
  •  
22.
  •  
23.
  • Magnusson, S, et al. (author)
  • Heme oxygenase-1, heme oxygenase-2 and biliverdin reductase in peripheral ganglia from rat, expression and plasticity
  • 2000
  • In: Neuroscience. - 1873-7544. ; 95:3, s. 821-829
  • Journal article (peer-reviewed)abstract
    • The expression of inducible and constitutive heme oxygenase and biliverdin reductase was studied in normal and cultured peripheral ganglia from adult rats, using immunocytochemistry and in situ hybridization. Dramatic changes were induced by one to two days' culturing of dorsal root ganglia, nodose ganglia, otic ganglia, sphenopalatine ganglia and superior cervical ganglia. An up-regulation of inducible heme oxygenase was found in satellite cells of the cultured nodose ganglia, dorsal root ganglia, sphenopalatine ganglia and otic ganglia, whereas only a few satellite cells in the superior cervical ganglia responded with an increase in inducible heme oxygenase immunoreactivity. In the superior cervical ganglia inducible heme oxygenase also appeared in a subpopulation of macrophages. During culturing, expression of inducible heme oxygenase immunoreactivity also increased in axons and in nerve cell bodies. In situ hybridization corroborated the immunocytochemical findings, revealing a strong up-regulation of inducible heme oxygenase messenger RNA in satellite cells, and less pronounced up-regulation in nerve cell bodies. Constitutive heme oxygenase immunoreactivity was found in most neurons in all of the ganglia studied. No significant changes in constitutive heme oxygenase immunoreactivity could be observed in cultured ganglia. Biliverdin reductase immunoreactivity was barely detectable in any of the normal ganglia; however, after culturing it appeared in axons, single nerve cell bodies and nerve cell nuclei. The results show that inducible heme oxygenase is up-regulated in peripheral ganglia after axonal injury, and suggest a role for carbon monoxide in cellular signaling and a requirement for the antioxidant (bilirubin) during the regeneration process.
  •  
24.
  • Marko-Varga, György, et al. (author)
  • Disposable polymeric high-density nanovial arrays for matrix assisted laser desorption/ionization-time of flight-mass spectrometry: I. Microstructure development and manufacturing
  • 2001
  • In: Electrophoresis. - 0173-0835. ; 22:18, s. 3978-3983
  • Journal article (peer-reviewed)abstract
    • In order to meet the expected enormous demand for mass spectrometry (MS)through-, put as a result of the current efforts to completely map the human proteome, this paper presents a new concept for low-cost high-throughput protein identification by matrix assisted laser desorption/ionization-time of flight-(MALDI-TOF)-MS peptide mapping using disposable polymeric high-density nanovial MALDI target plates. By means of microfabrication technology precision engineered nanovial arrays are fabricated in polymer substrates such as polymethylmethacrylate (PMMA) and polycarbonate (PC). The target plate fabrication processes investigated were precision. micromilling, cold embossing and injection moulding (work in progress). Nanovial dimensions were 300, 400 or 500 mum. Typical array densities were 165 nanovials/cm(2), which corresponds to 3300 vials on a full Applied Biosystems MALDI target plate. Obtained MALDI data displayed equal mass resolution, accuracy, signal intensity for peptide standards as compared to high-density silicon nanovial arrays previously reported by our group [7], as well as conventional stainless steel or gold targets.
  •  
25.
  •  
26.
  • Schreier, E, et al. (author)
  • Internal fields in magnetically ordered dysprosium, holmium and erbium
  • 2000
  • In: PHYSICA B. - : ELSEVIER SCIENCE BV. - 0921-4526. ; 289, s. 240-243
  • Journal article (peer-reviewed)abstract
    • Muon spin rotation data on single-crystalline samples of the heavy rare earth metals Dy, Ho and Er have been obtained as function of temperature in both the antiferromagnetic (afm) and the ferromagnetic (fm) state. In the afm state the temperature depende
  •  
27.
  • Tattersfield, Anne E, et al. (author)
  • Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial
  • 2001
  • In: The Lancet. - 1474-547X. ; 357:9252, s. 257-261
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Asthma guidelines recommend that long-acting inhaled beta-agonists should be used as maintenance therapy for patients with asthma inadequately controlled on an inhaled corticosteroid. We studied the safety and efficacy of the long-acting beta-agonist formoterol compared with terbutaline, each taken as needed, in patients with moderate to severe asthma. METHODS: Patients were taking an inhaled corticosteroid (mean dose 870 microg daily) and had a forced expiratory volume in 1 s (FEV1) of at least 50% predicted (mean 74%). Those requiring an inhaled beta-agonist three to eight times a day during the study run-in period (362 of 621 who started) were randomly assigned formoterol 4.5 microg or terbutaline 0.5 mg as needed by Turbuhaler in daily doses up to 54 microg and 6 mg, respectively, for 12 weeks in a double-blind, parallel-group study. Analyses were by intention to treat. FINDINGS: The 362 randomised patients (157 men, 205 women) had a mean age of 47 years. Patients taking formoterol had a longer time to their first severe asthma exacerbation (relative-risk ratio 0.55 [95% CI 0.34-0.89]), took fewer inhalations of study drug, and had larger increases in FEV1 (5%) and morning and evening peak expiratory flow (mean difference in increase 11 L/min and 8 L/min) than those taking terbutaline. No safety issues were identified. INTERPRETATION: When taken as needed, formoterol 4.5 microg provided better asthma control than terbutaline 0.5 mg in patients requiring moderate doses of relief medication despite inhaled corticosteroid treatment. Safety studies should be extended to a wider population of patients with asthma.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-27 of 27

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view